These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34023035)

  • 1. The Case | Euglycemic ketoacidosis in a patient on continuous renal replacement therapy.
    Stevens JS; Salazar-Schicchi J; Radhakrishnan J; Mohan S
    Kidney Int; 2021 Jun; 99(6):1507-1508. PubMed ID: 34023035
    [No Abstract]   [Full Text] [Related]  

  • 2. Euglycemic Ketosis During Continuous Kidney Replacement Therapy With Glucose-Free Solution: A Report of 8 Cases.
    Ting S; Chua HR; Cove ME
    Am J Kidney Dis; 2021 Aug; 78(2):305-308. PubMed ID: 33278477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Euglycemic ketoacidosis, a common and underecognized complication of continuous renal replacement therapy using glucose-free solutions.
    Coutrot M; Hékimian G; Moulin T; Bréchot N; Schmidt M; Besset S; Nieszkowska A; Franchineau G; Bourcier S; Bourron O; Luyt CE; Combes A
    Intensive Care Med; 2018 Jul; 44(7):1185-1186. PubMed ID: 29536124
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined metformin-associated lactic acidosis and euglycemic ketoacidosis.
    Schwetz V; Eisner F; Schilcher G; Eller K; Plank J; Lind A; Pieber TR; Mader JK; Eller P
    Wien Klin Wochenschr; 2017 Sep; 129(17-18):646-649. PubMed ID: 28865058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ‘Euglycemic’ Ketoacidosis in a Patient With Type 2 Diabetes Being Treated With Canagliflozin.
    Danford C; Chan P; Magill SB
    WMJ; 2016 Aug; 115(4):206-9. PubMed ID: 29099159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lactic Acidosis after Cardiac Surgery Treated by Continuous Renal Replacement Therapy in a Patient on Metformin;Report of a Case].
    Matsumura N; Saito M; Nitta Y; Yoshida S
    Kyobu Geka; 2020 Dec; 73(13):1121-1123. PubMed ID: 33271586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.
    Blau JE; Tella SH; Taylor SI; Rother KI
    Diabetes Metab Res Rev; 2017 Nov; 33(8):. PubMed ID: 28736981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric non-diabetic ketoacidosis: a case-series report.
    Bai K; Fu Y; Liu C; Xu F; Zhu M
    BMC Pediatr; 2017 Dec; 17(1):209. PubMed ID: 29258472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactation Ketoacidosis: A Systematic Review of Case Reports.
    Al Alawi AM; Al Flaiti A; Falhammar H
    Medicina (Kaunas); 2020 Jun; 56(6):. PubMed ID: 32560535
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic Acidosis in Postsurgical Patient on Canagliflozin and Metformin: A Case Report.
    Darwish AM
    A A Pract; 2019 Apr; 12(7):221-222. PubMed ID: 30234515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Euglycemic ketoacidosis as a cause of a metabolic acidosis in the Intensive Care Unit.
    John R; Yadav H; John M
    Acute Med; 2012; 11(4):219-21. PubMed ID: 23364105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketoacidosis in Euglycemic Patients With Type 2 Diabetes After Abdominal Surgery.
    Segebrecht R; Moncure M; Bennett A; Geehan D; Van Way CW; Weide L
    JPEN J Parenter Enteral Nutr; 2019 Sep; 43(7):937-940. PubMed ID: 30997672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Euglycemic ketoacidosis : a complication of SGLT2 inhibitors].
    Mizuno A; Lolachi S; Pernet A
    Rev Med Suisse; 2017 May; 13(565):1164-1167. PubMed ID: 28639760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy-an emerging problem and solutions offered by diabetes technology.
    Pfützner A; Klonoff D; Heinemann L; Ejskjaer N; Pickup J
    Endocrine; 2017 Apr; 56(1):212-216. PubMed ID: 28303514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives.
    Qiu H; Novikov A; Vallon V
    Diabetes Metab Res Rev; 2017 Jul; 33(5):. PubMed ID: 28099783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights Into the Recognition and Management of SGLT2-Inhibitor-Associated Ketoacidosis: It's Not Just Euglycemic Diabetic Ketoacidosis.
    Dizon S; Keely EJ; Malcolm J; Arnaout A
    Can J Diabetes; 2017 Oct; 41(5):499-503. PubMed ID: 28797889
    [No Abstract]   [Full Text] [Related]  

  • 17. Euglycemic diabetic ketoacidosis: A missed diagnosis.
    Nasa P; Chaudhary S; Shrivastava PK; Singh A
    World J Diabetes; 2021 May; 12(5):514-523. PubMed ID: 33995841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic acidosis of surprising origin in a 61-year-old female patient].
    Koyro TF; Thottakara T; Huber TB; Harendza S
    Internist (Berl); 2021 May; 62(5):549-554. PubMed ID: 33326044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Rare Cause of Life-Threatening Ketoacidosis: Novel Compound Heterozygous
    Kim YA; Kim SH; Cheon CK; Kim YM
    Yonsei Med J; 2019 Mar; 60(3):308-311. PubMed ID: 30799594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Euglycemic Ketoacidosis Caused by Sodium-Glucose Cotransporter 2 Inhibitors: A Case Report.
    Bobart SA; Gleason B; Martinez N; Norris K; Williams SF
    Ann Intern Med; 2016 Oct; 165(7):530-532. PubMed ID: 27699391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.